Profile
| Metric | Value |
|---|---|
| Full Name | Replimune Group, Inc. |
| Ticker | NASDAQ: REPL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | replimune.com |
| Employees | 479 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $7.75 | |
| Price, 1D Change | +11.83% | |
| $608M | ||
| - | ||
| - | ||
| 0.84 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.07 | ||
| EPS, 1Y Change | +5.31% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.07 | ||
| EPS Estimate | -$3.37 | |
| EPS Est. Change | -9.72% | |
| $0.00 | ||
| Revenue Estimate | $1.46M | |
| Revenue Est. Change | - | |
| Current Price | $7.75 | |
| Price Target | - | $12.00 |
| Price Tgt. Change | - | +54.84% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.27 | -$3.24 | +0.87% | |
| -$2.81 | -$3.07 | -9.13% | |
| -$3.37 | N/A | -9.72% | |
| -$2.06 | N/A | +32.81% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $2.01M | $0.00 | -100.00% | |
| $1.46M | N/A | - | |
| $65.83M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $7.75 | |
| $7.85 | ||
| SMA 200 vs Price | +1.23% | |
| $8.83 | ||
| SMA 50 vs Price | +13.90% | |
| 0.84 | ||
| $0.51 | ||
| 49.01 | ||
| 81.03% | ||
| 187.92% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$3.07 | ||
| -$3.50M | ||
| - | ||
| -$259.85M | ||
| - | ||
| -$247.30M | ||
| - | ||
| -$235.43M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.18 | ||
| 7.95 | ||
| 7.95 | ||
| - | ||
| - | ||
| -0.20 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.89 | ||
| -1.29 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $415.84M | ||
| $111.12M | ||
| $551.33M | ||
| $495.88M | ||
| $135.49M | ||
| $62.36M | ||
| $76.17M | ||
| $3.98M | ||
| $12.46M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $259.85M | ||
| $259.85M | ||
| $3.50M | ||
| $72.18M | ||
| $3.50M | ||
| $0.00 | ||
| -$1.31M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$192.25M | ||
| -$23.80M | ||
| $252.40M | ||
| $6.69M | ||
| -$198.94M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BMO Capital | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| Leerink Partners | → | |
| JP Morgan | → | |
| JP Morgan | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | → | |
| HC Wainwright & Co. | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
Screeners with REPL
FAQ
What is the ticker symbol for Replimune Group, Inc.?
The ticker symbol for Replimune Group, Inc. is NASDAQ:REPL
Does Replimune Group, Inc. pay dividends?
No, Replimune Group, Inc. does not pay dividends
What sector is Replimune Group, Inc. in?
Replimune Group, Inc. is in the Healthcare sector
What industry is Replimune Group, Inc. in?
Replimune Group, Inc. is in the Biotechnology industry
What country is Replimune Group, Inc. based in?
Replimune Group, Inc. is headquartered in United States
When did Replimune Group, Inc. go public?
Replimune Group, Inc. initial public offering (IPO) was on July 20, 2018
Is Replimune Group, Inc. in the S&P 500?
No, Replimune Group, Inc. is not included in the S&P 500 index
Is Replimune Group, Inc. in the NASDAQ 100?
No, Replimune Group, Inc. is not included in the NASDAQ 100 index
Is Replimune Group, Inc. in the Dow Jones?
No, Replimune Group, Inc. is not included in the Dow Jones index
When was Replimune Group, Inc. last earnings report?
Replimune Group, Inc.'s most recent earnings report was on February 3, 2026
When does Replimune Group, Inc. report earnings?
The next expected earnings date for Replimune Group, Inc. is May 21, 2026
Data Sources & References
- REPL Official Website www.replimune.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1737953/000162828026004805/0001628280-26-004805-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1737953/000173795325000009/0001737953-25-000009-index.htm
- REPL Profile on Yahoo Finance finance.yahoo.com/quote/REPL
- REPL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/repl